ARCHITECT AFP 03P36-26

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2016-11-18 for ARCHITECT AFP 03P36-26 manufactured by Abbott Ireland.

Event Text Entries

[60377723] An evaluation is in process. A follow-up report will be submitted when the evaluation is complete. Patient information; patient identifier - the complete first sid is (b)(6) and the follow-up sid is (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[60377724] The customer stated that the architect analyzer generated falsely elevated afp results on one patient. The results provided were: (b)(6) on (b)(6) 2016 = 346ng/ml / afp l3 fraction from outsource = 2. 6. The customer repeated a sample ((b)(6) on (b)(6) 2016) from the same patient /same day, different tube, and obtained 4. 7. There was no reported impact to patient management. There was no additional patient information provided.
Patient Sequence No: 1, Text Type: D, B5


[63871818] On 02dec2016 customer support provided the lot number- lot # from unknown to 62214fn00. The customer observed a single false elevated afp result using architect afp, list 3p36-25 ((b)(4) list number 3p36-26), lot 62214fn00. No patient sample was available to assist in the investigation. A review of complaints found no trend for lot 62214fn00. Accuracy testing was performed with a file sample of lot 62214fn00 and a serum based panel sample with a target concentration of 20 ng/ml. All specifications were met indicating that lot 62214fn00 is performing acceptably. A review of the manufacturing records for this lot did not identify any issues associated with the customer observation. A review of labeling shows adequate information is provided to address discrepant results including sample integrity / sample handling issues. The architect system operations manual provides troubleshooting for falsely elevated results. Based on all available information and this investigation, the assay performed as intended and no product deficiency was identified.
Patient Sequence No: 1, Text Type: N, H10


[74922022] The device evaluation was reassessed and concluded that a malfunction occurred, therefore the device was not performing as intended.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3008344661-2016-00072
MDR Report Key6112860
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2016-11-18
Date of Report2017-05-09
Date of Event2016-10-24
Date Mfgr Received2017-05-09
Device Manufacturer Date2016-04-13
Date Added to Maude2016-11-18
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNOEMI ROMERO-KONDOS, RN BSN
Manufacturer Street100 ABBOTT PARK ROAD DEPT. 09B9, LCCP1-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone224667-512
Manufacturer G1ABBOTT IRELAND
Manufacturer StreetDIAGNOSTICS DIVISION FINISKLIN BUSINESS PARK
Manufacturer CitySLIGO NA
Manufacturer CountryEI
Manufacturer Postal CodeNA
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameARCHITECT AFP
Generic NameALPHA-FETOPROTEIN
Product CodeLOK
Date Received2016-11-18
Catalog Number03P36-26
Lot Number62214FN00
Device Expiration Date2017-03-11
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT IRELAND
Manufacturer AddressDIAGNOSTICS DIVISION FINISKLIN BUSINESS PARK SLIGO NA EI NA


Patients

Patient NumberTreatmentOutcomeDate
10 2016-11-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.